|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
1.77/-0.63
|
企業價值
11.09M
|
資產負債 |
每股賬面淨值
1.12
|
現金流量 |
現金流量率
--
|
損益表 |
收益
28.83M
|
每股收益
2.75
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/17 00:31 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |